by Catherine Pitt, Mouhamed Ndiaye, Lesong Conteh et al.
Health Policy Plan – Published: 24 July 2017
Seasonal Malaria Chemoprevention (SMC) is recommended for children under 5 in the Sahel and sub-Sahel. The burden in older children may justify extending the age range, as has been done effectively in Senegal. The financial costs of providing SMC for children under ten represent 12% of combined government and international spending on malaria in Senegal and 1.2% of Senegal’s general government expenditure on health per capita, making SMC potentially affordable especially if it were to avert substantial curative care costs.